Vivo Capital »

Praxis Precision Medicines I shares owned by Vivo Capital

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Vivo Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 199k 53.00
2025-06-30 $7.0M 168k 42.05

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Verona Pharma Sponsored Ads (VRNA)
Cidara Therapeutics Common (CDTX)
Terns Pharmaceuticals Common (TERN)
Trevi Therapeutics Common (TRVI)
Avadel Pharmaceuticals Adr (AVDL)
Cogent Biosciences Common (COGT)
Sinovac Biotech SHS
Oric Pharmaceuticals Common (ORIC)
Geron Corp Common (GERN)
Compass Therapeutics Common (CMPX)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
Bright Minds Biosciences Common (DRUG)
Tourmaline Bio Common (TRML)

View all positions for Vivo Capital

Top funds holding Praxis Precision Medicines I

Henderson Group
Adage Capital Partners GP
BlackRock
Perceptive Advisors
Point72 Asset Management
Vanguard Group
Morgan Stanley
Cormorant Asset Management
State Street Corporation
Soleus Capital Management
Deerfield Management Company
Baker Bros. Advisors
Goldman Sachs Group
Driehaus Capital Management
Geode Capital Management

View all funds holding Praxis Precision Medicines I